STAAR Surgical (NASDAQ:STAA) Delivers Strong Q2 CY2026 Numbers But Stock Drops
Net Sales of $93.5 million, up 111% Y/Y Net Income of $8.1 million, with GAAP EPS of $0.16 Adjusted EBITDA ...
Barchart Research What to Expect from STAA Earnings STAA Generated August 11, 2026 Current Price $24.94 EPS Estimate $$0.05 Consensus Rating Hold Average Move 6.75% STAAR Surgical Reports Wednesday With...
What To Expect From STAAR Surgical’s (STAA) Q2 Earnings
1 Stock Under $50 on Our Buy List and 2 We Ignore
Barchart Research What to Expect from STAA Earnings STAA Generated August 4, 2026 Current Price $24.12 EPS Estimate $$0.06 Consensus Rating Hold Average Move 6.75% STAAR Surgical: The ICL Installed Base...
Deborah Andrews appointed Executive Vice President and Chief Financial Officer
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial...
1 High-Flying Stock with Impressive Fundamentals and 2 We Question